JAMES A BANKSON to Angiogenesis Inhibitors
This is a "connection" page, showing publications JAMES A BANKSON has written about Angiogenesis Inhibitors.
Connection Strength
0.140
-
Tumor T1 Relaxation Time for Assessing Response to Bevacizumab Anti-Angiogenic Therapy in a Mouse Ovarian Cancer Model. PLoS One. 2015; 10(6):e0131095.
Score: 0.075
-
Coronary microvascular pericytes are the cellular target of sunitinib malate-induced cardiotoxicity. Sci Transl Med. 2013 May 29; 5(187):187ra69.
Score: 0.065